Post marketing surveillance of functional food: The efficacy and safety of yogurt containing Bifidobacterium lactis DN-173 010 on constipation

Japanese Pharmacology and Therapeutics

Volumn 36, Issue 6, 2008, Pages 501-507

  Fukuda, Masahiro ^a   Mitsui, Hideaki ^a   Toyama, Manabu ^a   Kobayashi, Keiji ^a   Nozaki, Kyoko ^a   Izuoka, Toshio ^a   Nishitani, Masahito ^a   Yamaga, Ken Ichi ^a  

^a Osaka Association of General Physician   (Japan)

Author keywords

Abdominal pain and discomfort; Bifidobacterium lactis DN 173 010; Constipation

Indexed keywords

PROBIOTIC AGENT; YOGHURT;

ABDOMINAL DISCOMFORT; ABDOMINAL DISEASE; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BIFIDOBACTERIUM ANIMALIS; CLINICAL PRACTICE; CONSTIPATION; CONTROLLED STUDY; DEFECATION; FEMALE; FOOD ANALYSIS; FOOD COMPOSITION; FOOD INTAKE; FOOD SAFETY; FUNCTIONAL FOOD; HUMAN; JAPAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; POSTMARKETING SURVEILLANCE; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 51749091952     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Pochart P, Marteau P, Bouhnik Y, Goderel I, Bourlioux P, Rambaud JC. Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am J Clin Nutr 1992; 55: 78-80.
2. Duez H, Pelletier C, Cools S, Aissi E, Cayuela C, Gavini F, et al. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces. J Appl Microbiol 2000; 88: 1019-27.
3. Meance S, Cayuela C, Turchet P, Raimondi A, Lucas C, Antoine JM. A fermented milk with a Bifidobacterium probiotic strain DN-173 010 shortened oro-fecal gut transit time in elderly. Microbial Ecology in Health and Disease 2001; 13: 217-22.
4. Bouvier M, Meance S, Bouley C, Berta JL, Grimaud JC. Effects of consumption of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit time in healthy humans. Biosceince Microflora 2001; 20: 43-8.
5. Marteau P, Cuillerier E, Meance S, Gerhardt MF, Myara A, Bouvier M, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002; 16: 587-93.
6. Meance S, Cayuela C, Raimondi A, Turchet P, Lucas C, Antoine JM. Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium animalis strain DN-173 010 and yoghurt strains on gut transit time in the elderly. Microbial Ecology in Health and Diseases 2003; 15: 15-22.
7. Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26: 475-86.
8. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000; 130: 396S-402S.
9. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 2006; 100: 1171-85.
10. Madden JA, Hunter JO. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 2002; 88: S67-S72.